Knockdown of p53 Enhances LncRNA A2M‐AS1 Inhibition of Pancreatic Cancer Progression via Regulating MAPK Pathway
Cancer Medicine · 2025
DOI: 10.1002/cam4.70956 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Yu Cen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, RNA, Long Noncoding, Tumor Suppressor Protein p53, MAP Kinase Signaling System. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Project of Guangxi University of Chinese Medicine, the Project of Education Department of Guangxi Zhuang Autonomous Region, the National Natural Science Foundation of China.
Abstract (Originalsprache)
Purpose
Rapid progression in late‐stage is a characteristic of pancreatic cancer (PC), leading to mortality. The critical role of lncRNA A2M‐AS1 (long non‐coding RNA alpha‐2‐macroglobulin antisense RNA 1) is involved in cancer progression, but the upstream regulator of A2M‐AS1 in the PC progression phenotype remains elusive.
Methods
We conducted an integrated analysis using bioinformatics, in vitro experiments, and in vivo studies. Human PC tissues were analyzed for A2M‐AS1 and p53 expressions. The PANC‐1 and BxPC‐3 cell lines were used for functional assays, including cell proliferation, apoptosis, migration, and invasion assays. The role of p53 in regulating A2M‐AS1 was investigated through overexpression and knockdown studies, along with using a MAPK pathway inhibitor.
Results
We found that A2M‐AS1 is downregulated in PC tissues and that its high expression correlates with a better prognosis. p53 was identified as a negative regulator of A2M‐AS1, with its knockdown leading to increased A2M‐AS1 expression and decreased PC cell invasiveness. Mechanistically, p53 was shown to bind to the A2M‐AS1 promoter, modulating its transcriptional activity. The MAPK pathway was revealed as a downstream effector of the p53‐A2M‐AS1 axis, with its inhibition reversing the effects on PC cell behavior.
Conclusion
High A2M‐AS1 expression is associated with a better PC prognosis. A2M‐AS1 overexpression subdues PC cell development. Our study unveils a new mechanism by which p53 decreases A2M‐AS1 expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
- Department of Gastroenterology, Liuzhou People's Hospital, Liuzhou, China.
- Department of Gastroenterology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi Province, China.
- Department of General Medicine, Guangxi Medical University, Nanning, China.
ORCID-Profile: Shanyu Qin
Förderung
- the Project of Guangxi University of Chinese Medicine
- the Project of Education Department of Guangxi Zhuang Autonomous Region
- the National Natural Science Foundation of China
- the "139" Plan for Training High-Level Cadre Talents in Guangxi Medicine
- the School-level Project of Guangxi Medical University
- the Self-funded Research Project of Guangxi Zhuang Autonomous Region Health Commission
- National Natural Science Foundation of China
Zitieren
APA
Cen, Y., Luo, Y., Nan, Y., Kuang, W., Zhang, X., Lu, J., Xie, C., Xie, M., Chen, E., Jiang, H., & Qin, S. (2025). Knockdown of p53 Enhances LncRNA A2M‐AS1 Inhibition of Pancreatic Cancer Progression via Regulating MAPK Pathway. Cancer Medicine. https://doi.org/10.1002/cam4.70956
Vancouver
Cen Y, Luo Y, Nan Y, Kuang W, Zhang X, Lu J, et al. Knockdown of p53 Enhances LncRNA A2M‐AS1 Inhibition of Pancreatic Cancer Progression via Regulating MAPK Pathway. Cancer Medicine. 2025. doi:10.1002/cam4.70956
BibTeX
@article{Cen2025,
author = {Cen, Yu and Luo, Yihui and Nan, Yi and Kuang, Wenxi and Zhang, Xianglian and Lu, Jiexia and Xie, Chunxiao and Xie, Mingzhi and Chen, Enran and Jiang, Haixing and Qin, Shanyu},
title = {Knockdown of p53 Enhances LncRNA A2M‐AS1 Inhibition of Pancreatic Cancer Progression via Regulating MAPK Pathway},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.70956}
}
EUVIMED